"Multi Light and Drugs": a new technique to treat face photoaging. Comparative study with photorejuvenation.
Nonablative skin rejuvenation using laser, intense pulsed lights (IPLs), or radiofrequency techniques are becoming increasingly popular. In this paper, a novel protocol that integrates IPL sessions, low intense light and vitamin C, low-weight hyaluronic acid, betaglucan dermal injection versus IPL photorejuvenation as monotherapy is compared. A group of 100 patients, all women, with ages ranging from 35 to 65 years old (median age 56.3) with different degrees of photodamage was considered. A blinded control study was done. The patients were divided not randomly into two groups. These groups are similar for ages, skin types, and degrees of photoaging distribution. A first group of 40 patients had monotherapy consisting of seven sessions of IPL only. A second group of 60 patients had triple therapy consisting of seven sessions of IPL as well as nine sessions of low intense diode light and also biostimulation by drugs. Considering only the improvement in hyperpigmentations and teleangectasias, the monotherapy and the triple therapy show good results with no significant statistical difference between the two groups. Considering the improvement in skin texture and firmness in the group treated only with monotherapy, 30% (12 patients) had positive results, and 70% (28 patients) had poor results. In the group treated with triple therapy, 70% (42 patients) had positive results, and 30% (18 patients) had poor results, with the main differences in skin silicone negative imprints. On the basis of the data presented, the new technique of IPL, low intensity diode light, and multidrugs biostimulation seems to be a safe and effective method for skin rejuvenation and upgrades the effects of IPL in the fibroblasts' stimulation.
Mezzana
Paolo
P
Laser Unit, GeSer SrL, Via Merulana 61/A, 00185, Rome, Italy. pmezzana@yahoo.it
D000328:Adult; D000368:Aged; D001205:Ascorbic Acid; D003357:Cosmetic Techniques; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use; D054023:Lasers, Semiconductor; D008027:Light; D028022:Low-Level Light Therapy / Q000295:instrumentation* / Q000379:methods; D008297:Male; D008875:Middle Aged; D010789:Phototherapy; D015595:Skin Aging / Q000528:radiation effects*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D006820:Hyaluronic Acid; D001205:Ascorbic Acid